InvestorsHub Logo
Followers 24
Posts 3808
Boards Moderated 0
Alias Born 02/04/2013

Re: None

Thursday, 07/11/2013 9:05:16 PM

Thursday, July 11, 2013 9:05:16 PM

Post# of 345969
What Now?

Prior to ASCO, the next big thing was the presentations and how we as shareholders should focus on that.

Pre-First Line, The MOS was going to knock our socks off and that we could get BTD and or a partnership.

Pre-CC, Viral, BARDA, BTD, or even a Partnership

Post-CC, Now we must look forward to the possibility of a Clinical Trial with PD-1 and or other immunotherapy's

I think there is definitely possibilities with the science but I do seriously have my doubts with the BOD/Management and their duty to the shareholders. I know that 2nd Line was approved for P3, however, that is going to take money and time. I am not sure our management team is capable of leading it. The IR team definitely will not be able to properly communicate it to anyone.

I just do not want to be like some of you who have owned a Penny stock for over a decade. I am amazed how there is always the "NEXT SOMETHING", whenever nothing Great is clearly stated.

We always seem to have to decipher what was said and come up with theories. Unfortunately, all of these discussions go down roads which are circumstantial at best.

One of these days I would love to hear that something quantitative about a partnership and something other which makes WS and the scientific community believe.

I don't want my 62,000+ shares to be worth the same in 5 years or even have less shares.

Hoping for the best but starting to realize that we might merely be chasing the Pot of Gold at the end of the Bavi Rainbow.


Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News